Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
The second Forum set up under the Ministerial Industry Strategy Group (MISG) met on 24 September 2007 to debate whether making medicines available to patients at an earlier stage of their development was feasible and desirable. The topic of earlier access to medicines was chosen by the Panel to provide a preliminary consideration of a recommendation made by Sir David Cooksey in his Review of UK Health Research Funding. This report recommends conditional licensing of new drugs at an earlier stage in the development process (eg at the end of Phase II). It also recommends allowing clinical use under strict controls, plus a systematic programme of pilot studies of conditional licensing for new drugs at an earlier stage, allowing initial use by specialists - but not GPs - in the context of a randomised control trial.
Report from MISG Forum to consider earlier access to medicines 
